Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Northwest Biotherapeutics's pe ratio was 0.0× on Jan 31, 2023, against 76.8× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 0.0× | −0.0 |
| 2022 | Dec 30, 2022 | 0.0× | −76.8 |
| 2020 | Jul 31, 2020 | 76.8× | – |
See a number that looks wrong?